The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
F. Brunello(Ospedale San Luigi Gonzaga), G Emanuelli(University of Turin), Silvia Gonella(University of Turin), P Gastaldi, C Marcarino, Salvatore Martini(University of Campania "Luigi Vanvitelli"), Paolo Pasquero, G Calcamuggi
PubMed
January 1, 1993
Cited by 10
Related Papers
Anticoagulant treatment in COVID-19: a narrative review
|Journal of Thrombosis and Thrombolysis|2020|111
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)
|Hepatology International|2018|64
Ablation of Phosphoinositide 3-Kinase-γ Reduces the Severity of Acute Pancreatitis
|American Journal Of Pathology|2004|46
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index
|Journal of Clinical Virology|2009|41